English
中文繁體
中文简体

Dark
Light

Open Account

US OptionsDetailed Quotes

ERAS250516C1500

Watchlist

0.20
+0.05+33.33%

15min DelayClose May 2 16:00 ET

0.20High0.20Low

Erasca Stock Discussion

Sign in to post a comment

Swing Trading. 🔑

$Erasca (ERAS.US)$

2

$Erasca (ERAS.US)$

Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

1

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

$Erasca (ERAS.US)$
New Cancer Drug Data: Erasca's RAS Inhibitors Show Best-in-Class Potential at AACR 2025

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

2

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

$Erasca (ERAS.US)$

Morgan Stanley Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $4

$Erasca (ERAS.US)$

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

$Erasca (ERAS.US)$

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

1

$Erasca (ERAS.US)$
2.83
Let's Get Back To 3.+

No comment yet